CD274 and breast cancer: In addition, 5 of the 13 breast cancers from MMR variant carriers showed MMR protein loss consistent with the underlying germline variants, and the breast cancers with germline MMR variants showed a relatively high rate of TMB-high (2/10) and PD-L1 positive expression (9/13).